Apol1 Mediated Kidney Disease: A Conversation With Dr. Kirk Campbell

APOL1 Mediated Kidney Disease: A Conversation with Dr. Kirk Campbell

GlomCon Foundation

Pioneering Kidney Care: Innovations and Challenges Ahead with Dr. Kirk Campbell

Renal Research Institute

APOL1-mediated kidney disease: A conversation with Alonzo Mourning and Dr. Gerald Appel | NKF

National Kidney Foundation

Living with APOL1-mediated kidney disease: Dr. Kendra Richardson’s story | Vertex Pharmaceuticals

Vertex Pharmaceuticals

APOL1-Mediated Kidney Disease in Autoimmune Conditions

GlomCon Foundation

Emani's Journey | Caring for APOL1-Mediated Kidney Disease | AKF

Emerging Therapeutics: APOL1-Mediated Kidney Disease

GlomCon Foundation

APOL1-mediated kidney disease | Rare Kidney Disease | AKF

APOL1-Associated Nephropathy: Pathology, Mechanisms, and Clinical Utility - Dr. Barry Freedman

APOL1 Controversies Conference Plenary Presentation: APOL1 Diagnostics and Therapeutics

APOL1-Mediated Kidney Disease

Arkana Laboratories

APOL1-Mediated Kidney Disease Spotlight | American Kidney Fund

Webinar | APOL1-mediated kidney disease: Overview and Implications for Care | AKF

Role of the APOL1 Gene in Kidney Disease | Barry Freedman, MD

The Apollo Network-13

Understanding Genetic Kidney Disease: Insights on the APOL-1 Gene

Black Health Matters

Therochelle's Journey | Caring for APOL1-Mediated Kidney Disease | AKF

APOL1 Gene and African-American Susceptibility to Chronic Kidney Disease by John Sedor, MD

Vertex Forward: Exploring APOL1-Mediated Kidney Disease (AMKD) | Vertex Pharmaceuticals

Vertex Pharmaceuticals

Join Us for APOL1-Mediated Kidney Disease (AMKD) Awareness Day

APOL1 Controversies Conference Plenary: Epidemiology of APOL1 Kidney Disease